Slovenia - Lipid Modifying Medicine Use
Since 2014, Slovenia Lipid Modifying Medicine Use was up 4.6% year on year. At 140.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 5 comparing other countries in Lipid Modifying Medicine Use. Slovenia is overtaken by Norway, which was ranked number 4 with 145.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Australia at 140.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.5% compared to 2018. Lithuania witnessed the best average annual growth at +15% per year, while Slovakia recorded the worst performance at -7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 140.80 |
| 2018 | 136.20 |
| 2017 | 132.70 |
| 2016 | 125.10 |
| 2015 | 118.30 |
How does Slovenia rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 4 |
#4
Norway
|
145 | 2019 | +2.3 % | +3.3 % | View data | |
| 5 |
#5
Slovenia
|
141 | 2019 | +3.4 % | +4.6 % | View data | |
| 6 |
#6
Australia
|
140 | 2019 | +1.9 % | +1.3 % | View data | |